Cargando…
Tolerability and outcomes of monoclonal antibody therapy for COVID-19 during pregnancy
Autores principales: | Schenone, Claudio V., Thornton, Benjamin, Delgado, Arlin, Hale, Emma, Randis, Tara, Običan, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692707/ https://www.ncbi.nlm.nih.gov/pubmed/38046529 http://dx.doi.org/10.1016/j.xagr.2023.100286 |
Ejemplares similares
-
Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
por: Martinez-Baladejo, Maria T., et al.
Publicado: (2023) -
A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy
por: Chang, Mei H., et al.
Publicado: (2022) -
Giant Placental Chorangioma and Severe Ductal Arch Constriction: A Case Report With a Favorable Outcome
por: Schenone, Claudio V, et al.
Publicado: (2023) -
Monoclonal antibody treatment of symptomatic COVID-19 in pregnancy: initial report
por: Hirshberg, Jonathan S., et al.
Publicado: (2021) -
Assessment of geographic access to monoclonal antibodies in the United States
por: Rader, Benjamin, et al.
Publicado: (2022)